Niklas Hammar

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Early drug use of dapagliflozin prescribed by general practitioners and diabetologists in Germany”.

Early drug use of dapagliflozin prescribed by general practitioners and diabetologists in Germany

Diabetes Research and Clinical Practice(2017)10.1016/j.diabres.2016.10.025

N/A

0.241DataRank · unranked

4 citations

Katherine Tsai, Joseph Kim, Niklas Hammar, Matthew Hankins

Ten years preceding a diagnosis of neurodegenerative disease in Europe and Australia: medication use, health conditions, and biomarkers associated with Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis

EBioMedicine(2025)10.1016/j.ebiom.2025.105585

N/A

0DataRank · unranked

9 citations

Anna Freydenzon, Octave Guinebretiere, Karim Zaidi, Fen Yang, Weimin Ye +22 more